MedPath

FMI Food Effect Study of Doravirine/Islatravir (MK-8591A) in Healthy Japanese Participants

Phase 1
Conditions
Healthy volunteer
Registration Number
JPRN-jRCT2031200365
Lead Sponsor
Tanaka Yoshiyuki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
14
Inclusion Criteria

Healthy male or female aged 20 to 45 years old with BMI 18.5 to 25.0 kg/m2

Exclusion Criteria

Has a history of clinically significant abnormalities or diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
AUC0-inf, AUC0-last, AUC0-24, Cmax, Tmax, apparent terminal t1/2, C24, CL/F and V/F for Doravirine and Islatravir
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath